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The structure of the human bone morphogenetic protein-4 (BMP-4) gene has been characterized troni ¡i 
genomic cosmic! clone of about 38 kb. The transcriptional unit of the human BMP-4 gene is encoded by 5 exons 
and spans approximately 7 kb. The exon/intron organization of the human BMP-4 gene is similar to that of the 
mouse gene, with notable sequence differences in the 5' non-coding exons. The human BMP-4 gene has at least 
two functional promoters, which are used in a cell type specific manner, This observation is of fundamental 
relevance for understanding the specific role of BMP-4 in skeletal development and bone remodeling. «  im
Academic Press, Inc.
Bone morphogenetic protein-4 (BMP-4) is a member of the BMP family, which belongs to the 
transforming growth factor-J3 (TGF-ß) superfamily (1). BMPs can induce de novo cartilage and 
bone formation, and appear to be essential for skeletal development during mammalian embryo- 
genesis. Subcutaneous or intramuscular implantation of recombinant BMP-4 induces the formation 
of new bone. Furthermore, BMPs are involved in promoting bone healing in mammals (2). Re­
cently, it has become evident that during fracture healing the concentration of BMP-4 increases 
dramatically (3,4). These observations suggest an important role of BMP-4 in bone remodeling and 
fracture repair.
BMP-4 is not only involved in osteoinductive events, but also in many other developmental 
processes such as tooth morphogenesis (5), hematopoiesis (6) and neuronal differentiation (7). 
BMP-4 is one of the best evolutionary conserved growth factors and is able to induce mesoderm 
formation. This was first described for BMP-4 homologues in Drosophila mekmogaster (8) and 
Xenopus laevis (9), but also in mammals BMP-4 seems to be an important factor in mesoderm
formation and patterning (6, 10). 
Although the role of BMP-4 s
BMP
which are completely identical in their coding region, but are different in their 5' non-coding 
regions. One of these transcripts was isolated from an osteosarcoma cell line (1)
isolated from a prostate cancer cell line (11). The regulatory mechanisms underlying specific 
BMP-4 expression in human are unknown, but may reflect a combination of transcriptional and 
post-transcriptional control. For understanding the molecular mechanisms of the transcriptional 
control of human BMP-4, it is essential to isolate and characterize the complete BMP-4 gene. 
Although the overall structure of the mouse BMP-4 gene has already been described (12, 13), very 
little is known about the structure and functional organization of the human BMP-4 gene. A first 
report about the genomic structure of the human BMP-4 gene describes a fragment with two exons, 
containing the complete coding region (14). However, non-coding exons and promoter regions 
have not been identified yet.
In this report, we describe the isolation and characterization of a cosmid clone containing the
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entire human BMP-4 gene. Furthermore, a specific RT-PCR was developed and used to detect 
BMP-4 specific transcripts in several human cell lines. The results presented here suggest that the 
gene contains at least two functional promoters.
MATERIALS AND METHODS
Screening of a human genomic library. A 1,3 kb mouse Full length BMP-4 cDNA fragment (mmBMP4) was obtained 
by PCR on a lambda gt 10 8V2 day C57BL mouse cDNA library (gift from Dr. B. L. M. Hogan, Vanderbilt University, 
Nashville, TN), using primers F4 (5' CGCGGATCCCAAGT TTGTTCAAGATTGGCT 3') and R4 (5' CGCGGATCC- 
GCCTGATCTCAGCGGCACCC 3'), based on human BMP-4 cDNA sequence HSBMP2B (14). This probe was used to 
screen a human genomic cosmid library (16; gift from Mr. J. van Groningen, University of Nijmegen, The Netherlands), 
Approximately 3 x 10s cosmid clones were screened under non-stringent conditions in 5x SSC, 5x Denhardt’s, 0.5% SDS, 
100 jag/ml denatured herring sperm DNA at 65 °C overnight with the 32P-labeled mmBMP4 probe, and filters were washed 
up to 0.1 x SSC/0.1% SDS at 65 °C prior to autoradiography. One of the positive clones was subsequently purified to 
homogeneity by tertiary screening using the mmBMP4 probe.
Genomic clone mapping and DNA sequencing analysis. Cosmid DNA was purified and submitted to Southern blot 
analysis after digesting with appropriate restriction enzymes to generate a physical map. The DNA was transferred onto 
Hybond-N membrane (Amersham) and probed with the mmBMP4 fragment or BMP-4-specific primers (F4 and R4) to 
determine the orientation of the gene and approximate position of exons. Fragments that hybridized with these probes were 
subcloned into pBluescript II KS(-) (Stratagene) and analysed by DNA sequence analysis using the T7-Sequencing Kit 
(Pharmacia). For identi fication of the splice junctions of the BMP-4 gene, internal primers were chosen near possible splice 
junctions. These primers were used for direct cosmid DNA sequencing, according to the dsDNA Cycle Sequencing System 
(GibeoBRL). Genomic sequences were compared with the mouse BMP-4 gene (17) and several human BMP-4 cDNA 
sequences using the Fasta computer analysis program (Caos/Camm, The Netherlands).
Messenger RNA extraction and RT-PCR. Several human cell lines were used, including human forskin fibroblast 
(HF-V32), human embryonic kidney (HEK-293), primary human skin fibroblast (FI 1), undifferentiated Tera-2 cells 
(Tera2EC), RA- differentiated human Tera-2 cells (Tera2RA) (18) and the osteosarcoma cell lines MG-63, U-2 OS and 
Saos-2 (originally obtained from ATCC). A  1:1 mixture of Dulbecco’s modified Eagle’s medium (DMEM) and Ham’s F12 
medium supplemented with 10 % fetal calf serum (FCS) was used for culturing FI 1, HEK-293, HF-V32, MG-63, Saos-2 
and U-2 OS; aMEM/10 % FCS was used for Tera2EC and Tera2RA (5). Messenger RNA was extracted using the 
Micro-Fast Track mRNA isolation kit, according to the supplied protocol (Invitrogen Corp., San Diego, CA). From each 
sample approximately 20 ng mRNA was reverse transcribed according to the manufacturer’s protocol using 100 pmol of 
oligo(dT) primer and 200 units SuperScript-II (Gibco-BRL). Thereafter, 10% of the reaction volume were amplified in a 
PCR reaction, using 25 pmol of each primer (sense and antisense) and 2.5 U Taq DNA polymerase (Gibco-BRL). PCR 
reactions were transferred directly from ice to 95 °C for 5 min., followed by 36 cycles at 95 °C for 1 min., 52 °C for 1 min., 
72 °C for 2 min. and subsequently an extra extension step at 72 °C for 7 min. The nested PCR was under the same 
conditions, only with an annealing temperature of 54 °C instead of 52 °C. The sequences of the oligonucleotide primers for 
RT-PCR were the following: F IA  (5' ATCCGAGCTGAGGGACGCGAGCCT 3'), R IC  (5' CGTGTCACATTGTGGTG- 
GACC 3'), FIB (5' TGGCGAGCCCGCTACTGCAGGGAC 3'), R ID  (5' GCATTCGGTTACCAGGAATCATGG 3'), 
F2A (5' AGCGCAGGCCGAAAGCTGTTC 3'), F2B (5' CGTTTTCTCGACTCCGGGAAC 3'). The integrity of the
amplified fragments was confirmed by Southern blot hybridization, using a -,aP-labeled exon 3 specific-primcr (F4).
RESULTS
Isolation of the Human BMP-4 Gene
A 1.3 kb mmBMP4 probe was used to screen a human genomic cosmid library. This mouse 
cDNA probe was used because of the high degree of sequence conservation of BMP-4 cDNAs in 
different species (11). One of the positive cosmid clones with a 38 kb insert was further purified 
and analyzed. Restriction fragments, obtained by several enzymatic digestions of the isolated 
cosmid DNA, were analyzed by Southern blot hybridization with BMP-4 specific probes. Positive 
fragments were subcloned and their nucleotide sequences were determined. The obtained se­
quences were analyzed by nucleic acid homology searches, showing that the 38 kb genomic clone 
contained the entire BMP-4 gene. In order to determine the exon/intron structure, we isolated and 
sequenced two human BMP-4 transcripts from Tera2RA cells (results not shown). Sequence 
analysis revealed that one transcript was identical to a previously described cDNA from an osteo­
sarcoma cell line (19) and that the other transcript was identical to a cDNA from a prostate cancer 
cell line (11). Given the sequence information of both transcripts, together with the above men-
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tioned partial genomic sequences and genomic Southern blot analysis, we were able to resolve the 
exon/intron structure. We found that the gene consists of 5 exons, spanning approximately 7 kb 
(fig. 1 ). In addition, comparison of both transcripts with the genomic structure indicated that one 
transcript contains exon 1, 3,4 and 5 (named BMP4.1) and that the other contains exon 2, 3, 4 and 
5 (named BMP4.2). Both transcripts and the nucleotide position of the introns are shown in Figure 
2. To further characterize the human BMP-4 gene, we partially sequenced the exon/intron bound­
aries, using a combination of synthetic primers near possible splice sites (fig. 2) and subcloning of 
exon/intron containing fragments. The exact localization and sequence of splice sites is shown in 
Figure 3. All of the exon/intron boundaries defining the splice sites are conform the consensus 
sequence of AG at the 3' acceptor splice site and GT at the 5' donor splice site.
BMP-4 mRNA Expression
A specific RT-PCR method was used to detect the presence of the closely related BMP-4 
mRNAs in different tumor cell lines. Cell lines derived from various tissues were chosen on basis 
of previous reports on BMP-4 expression (1, 14). The BMP4.1 transcript is indicated by PCR using 
the primers FIA  and R1C, followed by a nested PCR with the primers FIB and R ID . To indicate 
the BMP4.2 transcript, a PCR using the primers F2A and R 1C was performed, followed by a nested 
PCR with the primers F2B and R ID . After amplification with the nested primer combinations, 
fidility of the BMP-4-specific PCR products was confirmed by hybridization using primer F4, an 
exon 3 specific primer. In fig. 4, a Southern blot is shown, containing the specific RT-PCR products 
indicating the presence of the two BMP-4 transcripts in various cell lines. Both transcripts were 
detected in the osteosarcoma cell lines U-2 OS and Saos-2. This was also the case for the 
embryonal kidney (HEK-293), the foreskin fibroblast (HF-V32) and the Tera-2RA cells. However, 
in Tera-2EC cells, the skin fibroblast (FI 1) and the osteosarcoma cell line MG63, only the BMP4.2 
transcript was present.
DISCUSSION
The genomic organization of the entire human BMP-4 gene has been characterized from a 38 kb 
cosmid clone. BMP-4 is encoded by a single gene, which was previously mapped to chromosome 
14q22-23 (15). The transcriptional unit of the gene contains 5 exons and spans approximately 7 kb. 
Sequence comparison with the mouse BMP-4 gene shows a high degree of homology in the 
regions and a similar exon/intron structure. However, notable sequence differences are observed in 
the non-coding exons 1 and 2. The human exon 2 shows only slight homology with a sequence in 
the mouse BMP-4 gene, starting about 150 bp upstream of the mouse exon 2 (12).
Molecular analysis showed that from the human BMP-4 gene at least two mRNAs are tran­
scribed, which share the same translation product but differ in their 5' region. The low level of 
expression, the high homology and the small difference in size between both BMP-4 transcripts, 
make it difficult to detect both transcripts by Northern blot hybridization. Therefore, we developed 
a sensitive RT-PCR to investigate the difference in BMP-4 transcription in various tumor cell lines.
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FIG. 1. Structure and restriction map of the human BMP-4 gene. About 10 kb of the gene containing the five exons is 
shown. Exons (solid bars) are indicated by the numbers I to 5. The coding region (shaded box) is shown together with the 
location of the proposed translation start site within exon 4 (arrow). Only restriction sites relevant to the present work are 
indicated: E, EcoRl; X, Xhol\ P, Pst\ and N, NcoL
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FIG. 2. Location of primers for the two BMP-4 transcripts. The location of introns (vertical lines), together with the first 
nucleotide position of each exon (numbers), are indicated. The coding region (shaded box) and exons (bold numbers) are 
shown. The first BMP-4 transcript (BMP4.1), is the same as HSBMP2B (19), which contains exons 1, 3, 4 and 5. From the 
second transcript (BMP4.2) only the length of exon 2 is indicated (11), which is spliced to exons 3, 4 and 5 at nucleotide 
position 262 of the HSBMP2B sequence (19). The sequences of exons 3, 4 and 5 of both transcripts are exactly the same. 
Primers (arrow heads) are shown as reverse (R) and forward (F).
We found that both transcripts are expressed in a cell type depending manner. Interestingly, the 
BMP-4.2 transcript was detectable in all cell lines tested, while the BMP4.1 transcript was not.
Both transcripts, together with the exon/intron sequences, suggest the presence of at least two 
putative promoters. A differential regulation of these promoters might explain the difference in cell 
line-specific expression of both mRNAs. Most likely, one promoter is located upstream of the 
non-coding exon 1 and the other is present just upstream of the non-coding exon 2. Because of the 
genomic organization and the RT-PCRs, it is unlikely that BMP4.2 is a splicing variant of BMP4.1. 
Upstream of the coding region (exon 4 and 5), a non-coding region (exon 3) is present in both 
transcripts. Since the translation start site is located in exon 4, the transcription initiation from both 
promoters will result in identical protein products.
A variant of the BMP-4 mRNA has recently been cloned from a human placental cDNA library 
(20). The 5' non-coding region of this transcript is different from the previously described mRNAs
EXON (SIZE) Exon 3’ intron (size) Exon 5'
Exon I (>262 bp) CCTATGgtgagcaaggctacc___ ..intron I (1.9 kb)
Exon 2 (> 77 bp) AACATGgtgggatttcctttc........ ......intron 2 (1.1 kb),
Exon 3 (125 bp) CTGTC Agtcagtagacacctg..... .....intron3 (1.2 kb)..
Exon 4 (377 bp) ACGAAGgtcagtctcattuac.,, . ......intron4 (1.0 kb)..
Exon 5 (>987 bp)
FIG. 3. Exon-intron boundaries of the BMP-4 gene. Nucleotide sequence for each intron-exon boundary and size of 
each exon and intron are shown. The 5' site of exon 1 and 2 is not shown, because of the unknown transcription initiation 
site. The 3' site of exon 5 is not shown because of its unknown poly(A+) addition site.
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FIG. 4. Southern blot of the BMP-4 specific RT-PCR products, derived from .several human cell lines, (a) BMP4.I-
specific PCR fragment of 181 bp. (b) BMP4.2-specific PCR fragment of 175 bp. The PCR fragments were hybridized with 
a '2P-labelcd exon 3 probe, which is primer F4 in figure 3. Human cell lines and negative controls are numbered, 1: MG-63, 
2: U-2 OS, 3: HF-V32, 4: HEK-293, 5: FI I, 6: EC, 7: RA, 8: Saos-2, 9: RT-H,0 and 10: H ,O.
and the deduced amino acid sequence indicated deletion of six N-terminal amino acids. Therefore, 
it can not be excluded that additional promoters might be present, upstream of the two putative 
promoters reported here. Various transcripts have also been observed for a BMP-4 homologue in 
Drosophila melanogaster, decapentaplegic protein (dpp) (21). These multiple dpp-specific mRNAs 
have been shown to result from several promoters and alternatively spliced 5'-untranslated exons. 
In the mouse, the BMP-4 gene also contains multiple non-coding regions and alternative promoters, 
which is in agreement with our results for the human gene (12, 13).
Regulation of BMP-4 gene expression and further evaluation of the different BMP-4 mRNAs 
will shed new light on the detailed role of this gene during osteogenesis. The presence of the two 
separate promoters and the diverse transcripts in several cell lines derived from different tissues, 
suggests a cell or tissue specific regulation of BMP-4 gene expression. To gain more insight in the 
transcriptional regulation of the BMP-4 gene in man, further characterization of the two putative 
promoters is in progress.
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